Physician profile
Robert Olive
NPI 1295729655
$690.41
in general payments reported to CMS, 2019-2025
12 companies · $57.75 in 2025
The $57.75 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $38.77 · 2021: $58.92 · 2022: $112 · 2023: $79.57 · 2024: $159 · 2025: $57.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $143.68 | 2019-2022 | |
| Djo, LLC | $99.20 | 2021-2025 | Cmf |
| Innovation Technologies INC | $95.36 | 2022 | |
| Pacira Therapeutics, INC. | $86.83 | 2019-2020 | |
| Heron Therapeutics, INC. | $64.69 | 2024 | Zynrelef |
| Boston Scientific Corporation | $57.74 | 2024 | Wavewriter Alpha Prime 16 |
| Davol INC. | $37.41 | 2025 | Arista |
| Vertex Pharmaceuticals Incorporated | $36.35 | 2024 | |
| Bioventus LLC | $21.59 | 2023 | Durolane |
| Pacira Pharmaceuticals Incorporated | $19.23 | 2023 | Exparel, Zilretta, Iovera |
| Smith+Nephew, INC. | $15.09 | 2019 | |
| Endo Pharmaceuticals INC. | $13.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Olive listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.